System1 Biosciences
Latest round
- Series A
Last raised
- Aug 2018
Total raised
- $25M
Investors
- 11
About System1 Biosciences
System1 Biosciences, Inc.Founded in 2017 in San Francisco, US, System1 Biosciences, Inc. focuses on transforming drug discovery processes. The company has not undergone any significant pivots.System1 Biosciences, Inc. offers advanced digital solutions for drug discovery, focusing on high-throughput screening and data analytics to support pharmaceutical research. Its services are tailored for biotech and pharmaceutical companies, enabling them to optimize their drug development pipelines.The company generates revenue through a project-based model, charging clients for its specialized services in drug discovery. Clients select service packages based on their specific research needs and project scopes, allowing for a flexible pricing strategy that accommodates various budget levels.System1 Biosciences, Inc. plans to expand its product offerings with new platforms aimed at integrating artificial intelligence in drug discovery processes, targeting a rollout by late 2023. Geographic expansion into European markets is also on the agenda, aiming for implementation in 2024.00 mn will be utilized to support these initiatives, enhancing technology development and market entry strategies.
Who invested in System1 Biosciences
11 investors across 1 round
See all investors in System1 Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 2, 2018
Amount
$25M
Investors
Questions about System1 Biosciences
Who invested in System1 Biosciences?
System1 Biosciences has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has System1 Biosciences raised?
System1 Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did System1 Biosciences last raise money?
System1 Biosciences's most recent round on record is a Series A, in Aug 2018.
What does System1 Biosciences do?
System1 Biosciences is a pharmaceuticals company.
Where is System1 Biosciences headquartered?
System1 Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like System1 Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at System1 Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like System1 Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.